Pharmacological and structural integrity of muscarinic M2 acetylcholine receptors produced in Sf9 insect cells.

Abstract	Muscarinic acetylcholine receptors (human m2 subtype), expressed in Sf9 cells, using the baculovirus system, were purified and found to display the expected ligand binding properties, whether membrane-bound or affinity-purified. The purified recombinant receptors were specifically photolabelled with p-N,N-[3H]dimethylamino and p-N,N-[3H]dibutylamino benzene diazonium derivatives. Electrophoretic patterns for covalent radioactive incorporation of the probes were essentially similar to those for [3H]propylbenzilylcholine mustard-labelled receptor sites but were dependent on the infection time of Sf9 cells. Pharmacological properties of the recombinant receptors being unaltered did not reflect structural integrity of the protein as substantial proteolytic fragmentation was detected at a prolonged infection time, i.e., at the highest level of expression. Selection of overexpression conditions, as illustrated here for muscarinic receptors, thus requires not only pharmacological controls, but also analysis of the covalently labelled protein under strongly dissociating conditions.
Authors	C Weill, F Autelitano, C Guenet, F Heitz, M Goeldner, B Ilien
Journal	European journal of pharmacology (Eur J Pharmacol) Vol. 333 Issue 2-3 Pg. 269-78 (Aug 27 1997) ISSN: 0014-2999 [Print] Netherlands
PMID	9314044 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	DNA, Complementary Muscarinic Agonists Muscarinic Antagonists Peptide Fragments Photoaffinity Labels Receptor, Muscarinic M2 Receptors, Muscarinic Recombinant Proteins
Topics	Animals Baculoviridae Cloning, Molecular DNA, Complementary (metabolism) Electrophoresis, Polyacrylamide Gel Humans Insecta (virology) Muscarinic Agonists (metabolism, pharmacology) Muscarinic Antagonists (metabolism, pharmacology) Peptide Fragments Photoaffinity Labels Receptor, Muscarinic M2 Receptors, Muscarinic (biosynthesis, drug effects, genetics) Recombinant Proteins (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!